Curriculum Vitae Ulrich Griese, PhD
Affiliation
Post doctoral scientist
Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tübingen
Auerbachstr. 112
D-70376 Stuttgart
phone: ++49-711-8101 3755
fax: ++49-711-859295
email: uli.griese@ikp-stuttgart.de
Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tübingen
Auerbachstr. 112
D-70376 Stuttgart
phone: ++49-711-8101 3755
fax: ++49-711-859295
email: uli.griese@ikp-stuttgart.de
Dr. Ulrich Griese
phone: ++49-711-8101 3755
Education and Professional Career
| 08/83-12/85 | Department of Human Genetics / University of Ulm, Germany |
| 01/86-07/90 | Institute of Human Genetics / University of Münster, Germany (group: Prof. Horst) |
| 08/90-12/90 | Institute of Human Genetics / University of Münster, Germany (group: Prof. Pawlowitzki) |
| 01/91- 12/09 | Dr. Margarete Fischer-Bosch-Institut für Klinische Pharmakologie / Stuttgart |
| since 01/10 | Robert Bosch Hospital / Stuttgart |
Selected References
- Griese EU, Kohne E, Horst J.Heterogeneity of the alpha-globin gene defects in German alpha-thalassemia affected families. Hum Genet. 1985;71(2):134-137
- Liebhaber SA, Griese EU, Weiss I, Cash FE, Ayyub H, Higgs DR, Horst J. Inactivation of human alpha-globin gene expression by a de novo deletion located upstream of the alpha-globin gene cluster. Proc Natl Acad Sci U S A. 1990 Dec;87(23):9431-9435.
- Horst J, Griese EU, Kleihauer E, Kohne E.Alpha-globin gene deletion causes alpha-thalassemia syndromes in two German families. Hum Genet. 1984;68(3):260-263.
- Evert B, Griese EU, Eichelbaum M. Cloning and sequencing of a new non-functional CYP2D6 allele: deletion of T1795 in exon 3 generates a premature stop codon. Pharmacogenetics. 1994 Oct;4(5):271-274.
- Griese EU, Zanger U, Brudermanns U, Gaedigk A, Mikus G, Morike K, Stuven T, Eichelbaum M. Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population. Pharmacogenetics. 1998 Feb;8(1):15-26.
- Griese EU, Läpple F, Eichelbaum M.Analysis of CYP2C19 *1, *2 and *3 by multiplex polymerase chain reaction. Pharmacogenetics. 1999 June; 9(3): 389-391
- Läpple F, v. Richter O, Fromm M, Richter T, Thon KP, Wisser H, Griese EU, Eichelbaum M, Kivistö KT.Differential expression and function of CYP2C isoforms in human intestine and liver. Pharmcogenetics. 2003 Sep, 13 (9):565-575
- Griese EU, Ilett KF, Kitteringham NR, Eichelbaum M, Powell H, Spargo RM, LeSouef PN, Musk AW, Minchin RF. Allele and genotype frequencies of polymorphic cytochromes P4502D6, 2C19 and 2E1 in aborigines from western Australia. Pharmacogenetics. 2001 Feb;11(1):69-76.
- Griese EU, Asante-Poku S, Ofori-Adjei D, Mikus G, Eichelbaum M. Analysis of the CYP2D6 gene mutations and their consequences for enzyme function in a West African population. Pharmacogenetics. 1999 Dec;9(6):715-723.
- Grunebach F, Griese EU, Schumacher K. Competitive nested polymerase chain reaction for quantification of human MDR1 gene expression. J Cancer Res Clin Oncol. 1994;120(9):539-544.